Integrated Diagnostics Holdings plc (IDHC) · 2026-09-11
IDH's first-half revenue rose 37% to EGP 4,856 million, alongside a 20% increase in tests to 23.6 million and higher revenue per patient. Hena Holdings increased its stake to 56.67% through its offer.
INTEGRATED DIAGNOSTICS HOLDINGS PLC (IDHC) · 2026-08-13
Integrated Diagnostics Holdings said Bidco's US$0.50 cash offer closed on 12 August 2026 after becoming unconditional, with Bidco counting 56.67% of shares.
Integrated Diagnostics Holdings (IDHC) · 2026-08-06
Integrated Diagnostics Holdings said Bidco's US$0.50 cash offer per share became unconditional on 28 July, with 56.66% of shares counted and acceptance open until 12 August 2026.
Integrated Diagnostics Holdings (IDHC) · 2026-07-30
The mandatory cash offer is now unconditional, while shareholders can still accept it until 12 August 2026.
Integrated Diagnostics Holdings (IDHC) · 2026-07-28
Integrated Diagnostics Holdings (IDH) said Hena Holdings Ltd, known as Bidco, is making a mandatory final cash offer for IDH shares it does not already hold.
Integrated Diagnostics Holdings (IDHC) · 2026-07-27
Bidco can count 289,108,783 shares, representing 49.73% of IDH's issued share capital, towards the offer's acceptance condition. Valid acceptances total 663,400 shares, or 0.11%.
Integrated Diagnostics Holdings (IDHC) · 2026-07-24
Bidco had received valid acceptances for 900 Integrated Diagnostics Holdings shares, or approximately 0.00% of issued share capital, as at 5.00 p.m. on 23 July 2026. Including its existing holding, Bidco counted 288,446,283 shares, representing approximately 49.61%, towards the offer's acceptance condition.
Integrated Diagnostics Holdings (IDHC) · 2026-07-23
Integrated Diagnostics Holdings said Bidco had not received any valid acceptances for the mandatory final cash offer as of 5.00 p.m. on 22 July 2026. Bidco counted 288,445,383 IDH Shares, about 49.61% of IDH's existing issued ordinary share capital, towards the acceptance condition.